Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Venous Thrombosis: later-stage trial registry
A small indexed set (11 trials) with no open enrollment listed right now.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · none currently recruiting · #1,577 of 28,707 conditions by registered trial count
Venous Thrombosis: 11 US clinical trials tracked, none currently recruiting.
Venous Thrombosis is the subject of 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 4 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Bristol-Myers Squibb, running 2 of these trials.
Enrollment posture brief
Registry condition venous-thrombosis
OPEN 0 | RECR 0% | LATE 4 | EARLY 1 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Venous Thrombosis has no open enrollment in this registry pull (11 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Venous Thrombosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Venous Thrombosis is recruiting below its size-band peers.
0 of 11 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Venous Thrombosis research.
Bristol-Myers Squibb accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Venous Thrombosis enrolment sits around 339 participants.
Median target enrolment is 339 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.
-
Venous Thrombosis research is mostly interventional.
8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
11 total, page 1 of 1
JETi Lower Extremity Venous Thrombosis
Abbott Medical Devices
NCT07027878
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Bristol-Myers Squibb
NCT00643201
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Bristol-Myers Squibb
NCT00633893
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Washington University School of Medicine
NCT00790335
Registry of AngioJet Use in the Peripheral Vascular System
Boston Scientific Corporation
NCT01086215
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
University of Pennsylvania
NCT00728819
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
Stanford University
NCT00185952
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
Venous Health Systems
NCT01240330
Tranexamic Acid and Blood Clots in Knee Surgery
University of New Mexi
NCT02867163
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
University of Pittsburgh
NCT00436787
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
ARCA Biopharma
NCT00322270
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Venous Thrombosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Venous Thrombosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Venous Thrombosis page
11 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Venous Thrombosis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bristol-Myers Squibb sponsors the most Venous Thrombosis trials on record, review their full trial history before evaluating a specific study. See Bristol-Myers Squibb's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Venous Thrombosis condition card totals 11 registered trials; most-linked intervention Recombinant tissue plasminogen activator (rt-PA); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.